Unicycive Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Unicycive therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Unicycive Therapeutics Inc Today - Breaking & Trending Today

Unicycive Therapeutics' (UNCY) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of Unicycive Therapeutics (NASDAQ:UNCY – Free Report) in a report issued on Wednesday, Benzinga reports. The brokerage currently has a $4.50 price objective on the stock. Several other brokerages have also recently commented on UNCY. Noble Financial started coverage on Unicycive Therapeutics in a research report on […] ....

United States , Piper Sandler , Unicycive Therapeutics Company Profile , Vivo Capital , Virtu Financial , Rosalind Advisors Inc , Unicycive Therapeutics Inc , Unicycive Therapeutics , Free Report , Get Free Report , Unicycive Therapeutics Daily ,

HC Wainwright Reiterates "Buy" Rating for Unicycive Therapeutics (NASDAQ:UNCY)

Unicycive Therapeutics (NASDAQ:UNCY – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a report released on Wednesday, Benzinga reports. They presently have a $4.50 price target on the stock. HC Wainwright’s price objective would indicate a potential upside of 437.76% from the stock’s previous close. A number of […] ....

United States , Piper Sandler , Vivo Capital , Virtu Financial , Rosalind Advisors Inc , Unicycive Therapeutics Inc , Unicycive Therapeutics Company Profile , Unicycive Therapeutics , Get Free Report , Noble Financial , Unicycive Therapeutics Daily ,

Unicycive Therapeutics' (UNCY) "Buy" Rating Reiterated at HC Wainwright

Unicycive Therapeutics (NASDAQ:UNCY – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $4.50 price target on the stock. HC Wainwright’s price objective points to a potential upside of 437.76% from the […] ....

United States , Piper Sandler , Virtu Financial , Vivo Capital , Unicycive Therapeutics Inc , Rosalind Advisors Inc , Unicycive Therapeutics , Get Free Report , Unicycive Therapeutics Daily ,

Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress - Unicycive Therapeutics (NASDAQ:UNCY)

Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress - Unicycive Therapeutics (NASDAQ:UNCY)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Satya Medicherla , Shalabh Gupta , European Renal Association , Shire International Licensing , Unicycive Therapeutics Inc , Reason Research , Exchange Commission , Company Or Unicycive , Moral Administration , Drug Administration , Renal Associates , Preclinical Model , Hyperphosphatemia Demonstrate , Relative Potency , Potential Candidate , Delayed Graft Function Related , Acute Kidney Injury , Chief Executive Officer , Enhanced Urinary Phosphorous Reduction , Comparative Study , Oxylanthanum Carbonate , Vice President , Preclinical Pharmacology , End Stage Kidney Disease ,

Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference

Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Shalabh Gupta , Unicycive Therapeutics Inc , Company Or Unicycive , Unicycive Therapeutics , Chief Executive Officer , Fireside Chat , Lytham Partners Spring ,